Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma
Victoria Menéndez1, José L Solórzano2, Mónica García-Cosío3
1Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain.
Summary
Advanced classical Hodgkin lymphoma (cHL) treatments fail for many patients. This study spatially maps CD4+ T cell subtypes within the tumor microenvironment, revealing immune signatures linked to patient outcomes.
Area of Science:
- Immunology
- Oncology
- Spatial Biology
Background:
- Classical Hodgkin lymphoma (cHL) has a significant non-response rate to standard therapies, particularly in advanced stages.
- The tumor microenvironment, especially CD4+ T cell populations, is crucial for understanding cHL and improving risk stratification.
- Current knowledge of immune signatures in cHL is limited, with a lack of spatial data.
Purpose of the Study:
- To spatially resolve CD4+ T cell subtypes influencing cHL patient outcomes.
- To identify novel immune signatures and transcriptional patterns within the cHL tumor microenvironment.
- To correlate spatial immune cell distribution with clinical data.
Main Methods:
- Utilized NanoString GeoMx digital spatial profiling technology on patient tissues.
- Performed gene-expression profiling on distinct functional areas of the tumor.
- Analyzed CD4+ T cell populations in relation to CD30 and PD-L1 expression levels.
Main Results:
- Depicted a complex spatial map of diverse CD4+ T cell subtypes with distinct functions and differentiation states.
- Identified specific locations enriched with particular CD4+ T cell populations.
- Revealed the flux of cytokines and chemokines and their relationship with clinical outcomes.
Conclusions:
- Spatial distribution of CD4+ T cells provides critical insights into cHL tumor microenvironment heterogeneity.
- Identified immune signatures and spatial patterns associated with clinical outcomes in cHL.
- Highlights the potential for spatial profiling in improving risk stratification for cHL patients.


